New York, NY, [April 20, 2016] — JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today Mark Fischer-Colbrie has been elected as the new chairman of the JDRF International Board of Directors (“IBOD”). Mr. Fischer-Colbrie will succeed JDRF IBOD Chairman John Brady, whose two-year term ends June 30.
↧